ABC diagnostika - Company finances
|
EUR
|
2022
From: 2022-08-02
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 7,215 | 363,146 | 1,210,756 | 2,198,425 |
| Profit before tax | -16,369 | 50,493 | 263,358 | 411,514 |
| Net profit | -16,369 | 43,114 | 231,140 | 329,427 |
| Equity | -12,369 | 30,745 | 264,222 | 557,649 |
| Liabilities | 23,843 | 247,850 | 375,917 | 716,356 |
| Non-current assets | 0 | 0 | 0 | 353,436 |
| Current assets | 10,980 | 277,916 | 639,719 | 918,954 |
| Total assets | 10,980 | 277,916 | 639,719 | 1,272,390 |
|
Taxes paid
|
||||
| STI taxes | - | 39,001 | 122,429 | 313,350 |
| Social insurance contributions | - | 38,437 | 115,957 | 249,266 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +4933.2% | +233.4% | +81.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -149.1% | 15.5% | 36.1% | 25.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 140.2% | 87.5% | 59.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -226.9% | 11.9% | 19.1% | 15.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -226.9% | 13.9% | 21.8% | 18.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 8.1 | 1.4 | 1.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 601 | 12,817 | 25,624 | 38,569 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ABC diagnostika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-18 | 2025-02-20 | 13.15 |
| 2025-01-23 | 2025-02-13 | 2.50 |
| 2024-01-23 | 2024-02-13 | 0.15 |
| 2023-11-16 | 2023-11-20 | 0.60 |
| 2023-10-27 | 2023-11-14 | 0.60 |
| 2023-10-25 | 2023-10-25 | 0.60 |
| 2023-10-17 | 2023-10-19 | 129.35 |
| 2023-08-17 | 2023-09-06 | 97.46 |
| 2023-07-24 | 2023-08-13 | 2.87 |
| 2023-04-18 | 2023-04-19 | 3183.52 |
| 2023-02-06 | 2023-02-07 | 1.08 |
| 2023-01-23 | 2023-02-03 | 1.08 |
| 2022-12-16 | 2023-01-09 | 64.38 |
| 2022-11-21 | 2022-12-14 | 64.37 |
| 2022-11-17 | 2022-11-18 | 64.37 |
ABC diagnostika - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company ABC diagnostika is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.14 |
| 2026-08-14 | 2026-08-17 | 1.25 |
| 2026-07-01 | 2026-07-07 | 217.44 |
| 2026-06-30 | 2026-06-30 | 180.54 |
| 2026-05-14 | 2026-05-14 | 282.71 |
| 2026-04-10 | 2026-04-11 | 10.0 |
| 2026-03-11 | 2026-03-12 | 125.6 |
| 2026-03-08 | 2026-03-10 | 125.48 |
| 2025-12-05 | 2025-12-05 | 3600.0 |
| 2025-05-01 | 2025-05-06 | 0.88 |
| 2025-01-01 | 2025-03-12 | 0.34 |
| 2024-10-12 | 2024-10-16 | 28.84 |
| 2024-10-01 | 2024-10-11 | 0.37 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ABC diagnostika, UAB (code 306124260) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €2.20M, up 81.6% year on year and 505.4% over two years, showing a strong expansion from €363.1K in 2023 and €1.21M in 2024. Net profit increased to €329.4K in 2025 from €231.1K in 2024 and €43.1K in 2023, while the net profit margin remained solid at 15.0% after 19.1% in 2024 and 11.9% in 2023. The balance sheet also strengthened: total assets reached €1.27M, equity €557.6K and liabilities €716.4K. The equity ratio stood at 43.8% and debt-to-equity at 1.28, indicating a moderate leverage profile. Profitability ratios were strong, with ROE at 59.1% and ROA at 25.9%, supported by an asset turnover of 1.73x. Revenue per employee was €38.6K, with profit per employee of €5.8K, pointing to a scalable operating model in 2025.